Technology Opportunities

Ariel (3)
BGN (96)
BioRap (11)
BIRAD (8)
Carmel (6)
Mor (21)
TASMC (1)
Technion (83)
Tel Hashomer (24)
Yeda (49)
Refine / Revise Search302 technologies found
page 1 of 16
3D tissue structures using differentiating embryonic stem cells (Technion)
Human embryonic stem (hES) cells hold promise as an unlimited source of cells for transplantation therapies. The present invention is a method for the control of hES cell proliferation and differentiation into complex, viable 3D tissue constructs. The invention describes the use of biodegradable ...
More Details...
3D vascularized pancreatic islets - for islets transplantation (Technion)
The present invention provides an advanced tissue-engineering technique for the development of 3D co-culture systems that reconstruct vascularization of pancreatic tissue ex-vivo. In this novel engineered 3D pancreatic model, isolated pancreatic islets can be co-cultured with endothelial cells. The ...
More Details...
A clot retrieval electrode catheter (BGN)
The present technology aims to re-vascularize or open an occluded artery in acute stroke and other conditions involved vessels occlusion. The technology apply a micro-catheter, designed to deliver an electrode wired to the clot at the occluded site by applying a positive pulse to the clot and ...
Scientific Contact: Itzhak Orion
More Details...
A Method and System for Detecting P-Waves in the surface Ecg Signal (BGN)
Scientific Contact: Yaniv Zigel
More Details...
A method for Evaluating A Mental Disorder (BGN)
Scientific Contact: Claude Brodski
More Details...
A method for treating large soft tissue defect (Technion)
Large soft tissue defects such as full- thickness abdominal wall defect or a large skin defect, caused by burns or cuts. The present technology proposes a robust engineered transplant to overcome these disadvantages. ...
More Details...
A Method in Improving Survival and Expansion of Hematopoietic Stem Cells (Yeda)
Summary hematopoietic cells. HSCs have the capacity to both self-renew and to differentiate, and they migrate from the bone marrow to the blood upon demand. Since HSCs can differentiate to a variety of cell types, including immune system cells, they have a huge therapeutic potential. Indeed, bone ...
Scientific Contact: Idit Shachar
More Details...
A Method of Treating Neurodegenerative Diseases (BGN)
Scientific Contact: Alon Monsonego
More Details...
A miniature cryocooler activated by piezoelectric elements in resonance (Technion)
Rotary and conventional linear compressors tend to have higher maintenance requirements reducing machine lifetime. This invention introduces a miniature cryogenic cryocooler, based on a linear piezoelectric compressor that offers superior efficiency, power density and speed of operation in ...
More Details...
A New Biomarker for early Prostate Cancer detection (BioRap)
Prostate cancer (CaP), an adenocarcinoma of the prostate, is the most common cancer in American males over the age of 55 and the second cause of cancer-related mortality. The current diagnosis of prostate cancer is based on the measurements of serum prostate-specific antigen (PSA) levels. ...
More Details...
A new drug and gene delivery system to the brain (Technion)
Though the brain has relatively high blood flow, it remains one of the least accessible organs for drug delivery due to the blood-brain barrier (BBB) and cerebrospinal fluid barrier, which separate the brain from its blood supply and control the movement of compounds in and out of the brain. Our ...
More Details...
A New Kit for Prediction and Prevention of Diabetes-Related Complications (BioRap)
A test method based on a genetic polymorphism in the Haptoglobin gene identifies those individuals with Diabetes who are at high risk for developing heart, eye and kidney disease and who benefit from specific drug treatments, has been validated in multiple clinical trials worldwide. Diabetes is ...
More Details...
A Novel Alginate Hydrogel Based Controlled and Targeted Delivery System (BGN)
Controlled drug delivery systems offer numerous advantages compared to conventional dosage forms including improved efficacy, reduced toxicity, and improved patient compliance and convenience. Controlled release systems aim to improve the effectiveness of drug therapy. This improvement can take ...
Scientific Contact: Smadar Cohen
More Details...
A Novel Approach for Controlling Gene Expression (Arbirtium - a Novel approach) (Yeda)
Summary One of the challenges in the areas of synthetic biology and its clinical applications, is the capacity to control the induction of different genes, whether for the purpose of activating genetic circuits or inducing the expression of a specific protein. Present approaches are limited to the ...
Scientific Contact: Rotem Sorek
More Details...
A Novel Approach for Treating Cancer and Collagen-Associated Diseases by Using Anti-LOXL-2 Antibody (Yeda)
Summary Disruption to the Extra-Cellular Matrix (ECM) is associated with many pathological conditions, such as various cancer types and tissue fibrosis, and also correlates with high tumor malignancy. Therefore, controlling ECM composition and morphology is considered a potential treatment for ...
Scientific Contact: Irit Sagi
More Details...
A Novel Hydrogel Based Injectable Bilayer Device for Simultaneous Regeneration of Articular Cartilage and Subchondral Bone (BGN)
A subchondral defect is usually characterized by a structural breakdown of the articular cartilage and the bone underneath due to trauma or disease, leading to chronic disabilities. Treating such defects is an important medical target since in the adult patient, damaged cartilage cannot ...
Scientific Contact: Smadar Cohen
More Details...
A novel medical device for the treatment of Hallux Valgus (Mor)
Scientific Contact: Dror Robinson
More Details...
A Novel Method for Detecting Activation of Necroptosis via Exosome Analysis (Yeda)
Summary Numerous medical conditions are related to inflammation, such as pancreatitis, psoriasis, inflammatory bowel disease, atherosclerosis, neurodegeneration, and more. However, determination of inflammation in the body, especially at early stages of a pathology is difficult to assess. ...
Scientific Contact: David Wallach
More Details...
A Novel Method for Treating Drug-Resistant Lung Cancer Using a Combination of Antibodies (Yeda)
Summary A novel method for treating tyrosine kinase inhibitor (TKI)-resistant cancer, by using a combination of three different antibodies. Lung cancer is known as one of the most fatal forms of cancer. Notably, standard treatments for other cancer types (e.g. TKIs and mAbs), have shown only a ...
Scientific Contact: Yosef Yarden
More Details...
A Novel Method of Preventing or Treating Secondary Infections by Inhibition of Membrane Type I Matrix-Metalloproteinase-1 (Yeda)
Summary A novel method of preventing secondary infections, by inhibition of membrane type I matrix-metalloproteinase-1 (MT1-MMP), which reduces degradation of the extra-cellular matrix. Pathogens that infect the respiratory system are the cause of some of the most dangerous infections, especially ...
Scientific Contact: Irit Sagi
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.